How AI is applied across API Evangelist and APIs.io. Read my AI disclosure →
API Evangelist API Evangelist
Discovery
Learnings
Guidance
Toolbox
Alignment
API Evangelist LLC

Five-Year PHERGain Data Support Selective Chemotherapy Reduction, Not Broad Omission

calendar_today November 1, 2026 person NewTqnia domain newtqnia

Five-year PHERGain results support a PET- and pathology-guided strategy that spared some women with early HER2-positive breast cancer from chemotherapy. The phase 2 trial was not designed to prove equivalence with standard treatment, and its chemotherapy-free subgroup was defined after response became known.

open_in_new Read original post